Article
Preventing breast cancer in high-risk women, 2008.
Oncology (Williston Park, N.Y.) - 1 May 2008
Vogel Victor G
Abstract excerpt
Several large, prospective trials have evaluated tamoxifen compared with placebo for breast cancer risk reduction in women at increased risk for breast cancer. Analysis of the large, prospective breast cancer risk-reduction trials that used tamoxifen estimated that tamoxifen decreased breast cancer incidence by 38% on average and estrogen receptor-positive tumors by 48%. Tamoxifen is known to have several serious...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
